Mortality and Hospital Stay Associated with Resistant and Bacteremia: Estimating the Burden of Antibiotic Resistance in Europe

English version České info

Background:
The relative importance of human diseases is conventionally assessed by cause-specific mortality, morbidity, and economic impact. Current estimates for infections caused by antibiotic-resistant bacteria are not sufficiently supported by quantitative empirical data. This study determined the excess number of deaths, bed-days, and hospital costs associated with blood stream infections (BSIs) caused by methicillin-resistant Staphylococcus aureus (MRSA) and third-generation cephalosporin-resistant Escherichia coli (G3CREC) in 31 countries that participated in the European Antimicrobial Resistance Surveillance System (EARSS).

Methods and Findings:
The number of BSIs caused by MRSA and G3CREC was extrapolated from EARSS prevalence data and national health care statistics. Prospective cohort studies, carried out in hospitals participating in EARSS in 2007, provided the parameters for estimating the excess 30-d mortality and hospital stay associated with BSIs caused by either MRSA or G3CREC. Hospital expenditure was derived from a publicly available cost model. Trends established by EARSS were used to determine the trajectories for MRSA and G3CREC prevalence until 2015. In 2007, 27,711 episodes of MRSA BSIs were associated with 5,503 excess deaths and 255,683 excess hospital days in the participating countries, whereas 15,183 episodes of G3CREC BSIs were associated with 2,712 excess deaths and 120,065 extra hospital days. The total costs attributable to excess hospital stays for MRSA and G3CREC BSIs were 44.0 and 18.1 million Euros (63.1 and 29.7 million international dollars), respectively. Based on prevailing trends, the number of BSIs caused by G3CREC is likely to rapidly increase, outnumbering the number of MRSA BSIs in the near future.

Conclusions:
Excess mortality associated with BSIs caused by MRSA and G3CREC is significant, and the prolongation of hospital stay imposes a considerable burden on health care systems. A foreseeable shift in the burden of antibiotic resistance from Gram-positive to Gram-negative infections will exacerbate this situation and is reason for concern.

: Please see later in the article for the Editors' Summary

Vyšlo v časopise: Mortality and Hospital Stay Associated with Resistant and Bacteremia: Estimating the Burden of Antibiotic Resistance in Europe. PLoS Med 8(10): e32767. doi:10.1371/journal.pmed.1001104
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pmed.1001104

Souhrn

Zdroje

1. 2010 BURDEN: Burden of resistance and disease in European nations [website]. Available: http://www.eu-burden.info/. Accessed 1 October 2010

2. BiedenbachDJMoetGJJonesRN 2004 Occurrence and antimicrobial resistance pattern comparisons among bloodstream infection isolates from the SENTRY Antimicrobial Surveillance Program (1997–2002). Diagn Microbiol Infect Dis 50 59 69

3. De KrakerMEAWolkewitzMDaveyPGKollerBergerWJ 2011 Clinical impact of antimicrobial resistance in European hospitals: excess mortality and length of hospital stay related to methicillin-resistant Staphylococcus aureus bloodstream infections. Antimicrob Agents Chemother 55 1598 1605

4. De KrakerMEAWolkewitzMDaveyPGKollerWBergerJ 2011 Burden of antimicrobial resistance in European hospitals: excess mortality and length of hospital stay associated with bloodstream infections due to Escherichia coli resistant to third-generation cephalosporins. J Antimicrob Chemother 66 398 407

5. European Antimicrobial Resistance Surveillance Network 2010 Reporting protocol: EARS-Net 2010. European Centre for Disease Prevention and Control. Available: http://www.ecdc.europa.eu/en/activities/surveillance/EARS-Net/Documents/2010_EARS-Net_Reporting%20Protocol.pdf. Accessed 1 November 2010

6. European Antimicrobial Resistance Surveillance System 2008 EARSS annual report 2007: on-going surveillance of S. pneumoniae, S aureus, E. coli, E. faecium, E. faecalis, K. pneumoniae, P. aeruginosa. Bilthoven: National Institute for Public Health and the Environment. Available: http://www.ecdc.europa.eu/en/activities/surveillance/EARS-Net/Documents/2007_EARSS_Annual_Report.pdf. Accessed 1 November 2010

7. Eurostat 2010 Statistics Database [database]. Available: http://epp.eurostat.ec.europa.eu/portal/page/portal/eurostat/home. Accessed 1 August 2010

8. Organisation for Economic Co-operation and Development 2010 Health care resources: Hospital beds [database]. Available: http://stats.oecd.org/index.aspx?DataSetCode=HEALTH_STAT. Accessed 8 September 2011

9. World Health Organization 2010 Global health observatory [database]. Available: http://apps.who.int/ghodata/. Accessed 1 August 2010

10. BenderRBlettnerM 2002 Calculating the “number needed to be exposed” with adjustment for confounding variables in epidemiological studies. J Clin Epidemiol 55 525 530

11. AdamTEvansDBMurrayCJ 2003 Econometric estimation of country-specific hospital costs. Cost Eff Resour Alloc 1 3

12. World Health Organization 2011 WHO-Choice unit cost estimates for service delivery. Available: http://www.who.int/choice/country/WHO-CHOICEunit_cost_estimates_2007_2008.xls. Accessed 8 September 2011

13. Eurostat 2010 Harmonized indices of consumer prices: July 2010. Available: http://epp.eurostat.ec.europa.eu/cache/ITY_OFFPUB/KS-QA-10-036/EN/KS-QA-10-036-EN.PDF. Accessed 1 October 2010

14. Central Bureau of Statistics 2010 Statistical abstract of Israel 2010: consumer price index. Available: http://www1.cbs.gov.il/shnaton61/st13_03.pdf. Accessed 1 October 2010

15. Croatian Bureau of Statistics 2005 Consumer price indices. Available: http://www.dzs.hr/default_e.htm [search term: consumer price indices]. Accessed 1 October 2010

16. Turkish Statistical Institute 2010 Consumer Price Index Turkey. Available: http://www.turkstat.gov.tr/PreIstatistikTablo.do?istab_id=652. Accessed 1 October 2010

17. OANDA Corporation 2011 Historical exchange rates. Available: http://www.oanda.com/currency/historical-rates. Accessed 8 September 2011

18. McCormickAWWhitneyCGFarleyMMLynfieldRHarrisonLH 2003 Geographic diversity and temporal trends of antimicrobial resistance in Streptococcus pneumoniae in the United States. Nat Med 9 424 430

19. MeviusDJSprengerMJWegenerHC 1999 EU conference ‘The Microbial Threat’. Int J Antimicrob Agents 11 101 105

20. European Antimicrobial Resistance Surveillance System 2009 EARSS annual report 2008: on-going surveillance of S. pneumoniae, S aureus, E. coli, E. faecium, E. faecalis, K. pneumoniae, P. aeruginosa. Bilthoven: National Institute for Public Health and the Environment. Available: http://www.ecdc.europa.eu/en/activities/surveillance/EARS-Net/Documents/2008_EARSS_Annual_Report.pdf. Accessed 1 November 2010

21. DevauxIManisseroDFernandez de la HozKKremerKvan SoolingenD 2010 Surveillance of extensively drug-resistant tuberculosis in Europe, 2003–2007. Euro Surveill 15 19518

22. CosgroveSE 2006 The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs. Clin Infect Dis 42 Suppl 2 S82 S89

23. JonesRN 2003 Global epidemiology of antimicrobial resistance among community-acquired and nosocomial pathogens: a five-year summary from the SENTRY Antimicrobial Surveillance Program (1997–2001). Semin Respir Crit Care Med 24 121 134

24. BoyceJMWhiteRLSpruillEY 1983 Impact of methicillin-resistant Staphylococcus aureus on the incidence of nosocomial staphylococcal infections. J Infect Dis 148 763

25. AsgeirssonHGudlaugssonOKristinssonKGHeiddalSKristjanssonM 2011 Staphylococcus aureus bacteraemia in Iceland, 1995–2008: changing incidence and mortality. Clin Microbiol Infect 17 513 518

26. WyllieDHCrookDWPetoTE 2006 Mortality after Staphylococcus aureus bacteraemia in two hospitals in Oxfordshire, 1997–2003: cohort study. BMJ 333 281

27. WilsonJElgohariSLivermoreDMCooksonBJohnsonA 2011 Trends among pathogens reported as causing bacteraemia in England, 2004–2008. Clin Microbiol Infect 17 451 458

28. MarchaimDZaidensteinRLazarovitchTKarpuchYZivT 2008 Epidemiology of bacteremia episodes in a single center: increase in Gram-negative isolates, antibiotics resistance, and patient age. Eur J Clin Microbiol Infect Dis 27 1045 1051

29. SaxHPittetD 2002 Interhospital differences in nosocomial infection rates: importance of case-mix adjustment. Arch Intern Med 162 2437 2442

30. TongENClementsACHaynesMAJonesMAMortonAP 2009 Improved hospital-level risk adjustment for surveillance of healthcare-associated bloodstream infections: a retrospective cohort study. BMC Infect Dis 9 145

31. JarlierVArnaudICarbonneA 2009 Surveillance des bactéries multirésistantes dans les établissements de santé en France. Réseau BMR-Raisin. Résultats 2007. Available: http://www.invs.sante.fr/publications/2009/bmr_raisin_2007/BMR_Raisin_resultats_2007.pdf. Accessed 1 November 2010

32. BenfieldTEspersenFFrimodt-MollerNJensenAGLarsenAR 2007 Increasing incidence but decreasing in-hospital mortality of adult Staphylococcus aureus bacteraemia between 1981 and 2000. Clin Microbiol Infect 13 257 263

33. Antibiotika Resistenz Surveillance 2010 Resistenzübersicht [database]. Robert Koch-Institut. Available: https://ars.rki.de/CommonReports/Resistenzuebersicht.aspx. Accessed 3 April 2011

34. WolkewitzMFrankUPhilipsGSchumacherMDaveyP 2011 Mortality associated with in-hospital bacteraemia caused by Staphylococcus aureus: a multistate analysis with follow-up beyond hospital discharge. J Antimicrob Chemother 66 381 386

35. LambertMLSuetensCSaveyAPalomarMHiesmayrM 2011 Clinical outcomes of health-care-associated infections and antimicrobial resistance in patients admitted to European intensive-care units: a cohort study. Lancet Infect Dis 11 30 38

36. European Centre for Disease Control, European Medicines Agency 2009 The bacterial challenge: time to react. A call to narrow the gap between multi-drug resistant bacteria in the EU and the development of new antibacterial agents. Available: http://www.ecdc.europa.eu/en/publications/Publications/0909_TER_The_Bacterial_Challenge_Time_to_React.pdf. Accessed 1 November 2010

37. World Health Organization 2004 The global burden of disease: 2004 update. Available: http://www.who.int/healthinfo/global_burden_disease/2004_report_update/en/index.html. Accessed 1 November 2010

38. StruelensMJMonnetDL 2010 Prevention of methicillin-resistant Staphylococcus aureus infection: is Europe winning the fight? Infect Control Hosp Epidemiol 31 Suppl 1 S42 S44

39. GrundmannHLivermoreDMGiskeCGCantonRRossoliniGM 2010 Carbapenem-non-susceptible Enterobacteriaceae in Europe: conclusions from a meeting of national experts. Eurosurveillance 15 19711

40. KumarasamyKKTolemanMAWalshTRBagariaJButtF 2010 Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis 10 597 602